Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA Approves Drug for Acute Coronary Syndromes

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta ( ticagrelor ) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

(UPDATE 12/15) FDA Announces New Safety Recommendations For High-Dose Simvastatin

The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy , particularly during the first 12 months of use.

REFINE

medications
- - Apply Brilinta filter Brilinta (1) Apply Brilinta filter
  - Apply Vytorin filter Vytorin (1) Apply Vytorin filter
  - Apply Zocor filter Zocor (1) Apply Zocor filter
conditions
- - Remove Cardiovascular filter (-) Remove Cardiovascular filter Cardiovascular
    Remove Atherosclerosis filter (-) Remove Atherosclerosis filter Atherosclerosis
    
    Apply Heart Attack filter Heart Attack (2) Apply Heart Attack filter
    
    Apply High Cholesterol filter High Cholesterol (2) Apply High Cholesterol filter
    
    Apply Stroke filter Stroke (1) Apply Stroke filter
  - Apply Patient Safety Education filter Patient Safety Education (1) Apply Patient Safety Education filter